Bio Path Holdings Inc expected to post a loss of 45 cents a share - Earnings Preview
* Bio Path Holdings Inc BPTH.OQ BPTH.O is expected
to show no
change in quarterly revenue when it reports results on May 12.
*
* Refinitiv's mean analyst estimate for Bio Path Holdings
Inc is
for a loss of 45 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts had risen by
about 3.2%
in the last three months.
* Wall Street's median 12-month price target for Bio Path
Holdings
Inc is $13, above its last closing price of $1.49.
This summary was machine generated May 10 at 12:49 GMT. All
figures in US dollars unless otherwise stated
Recent news on Bio Path Holdings
See all newsBrief: Bio-Path Holdings Seeks Financing For Turnaround & Strategic Actions
Brief: Bio-Path Holdings Reports Full Year 2024 Financial Results
Brief: Bio-Path Holdings Announces Pre-Clinical Results Signaling Increased Potential for BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients
Brief: Bio-Path Provides Key Clinical Updates
Brief: Bio-Path Holdings Provides Update From Phase 1/1B Clinical Trial Of Bp1002 For Treatment Of Refractory/Relapsed Acute Myeloid Leukemia